Treatment of severe covid-19 with interleukin 6 receptor inhibition

被引：1
|
作者：
Rajasundaram, Skanda [1 ]
Burgess, Stephen [2 ]
Gill, Dipender [3 ]
机构：
[1] Univ Oxford, Oxford, England
[2] Univ Cambridge, Cambridge, England
[3] Imperial Coll London, Dipender Gill, London SW7 2BX, England
来源：
BMJ MEDICINE | 2022年 / 1卷 / 01期
基金：
英国惠康基金;
关键词：
D O I：
10.1136/bmjmed-2022-000144
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle
    Farina, Nicola
    Dagna, Lorenzo
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 101 : 37 - 38
  • [2] The Role of Interleukin-6 in the Pathogenesis, Prognosis and Treatment of Severe COVID-19
    Giannakodimos, Ilias
    Gkountana, Georgia-Vasiliki
    Lykouras, Dimosthenis
    Karkoulias, Kiriakos
    Tsakas, Sotiris
    [J]. CURRENT MEDICINAL CHEMISTRY, 2021, 28 (26) : 5328 - 5338
  • [3] The role of Interleukin 6 inhibitors in therapy of severe COVID-19
    Nasonov, E.
    Samsonov, M.
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
  • [4] Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concern
    Akinosoglou, Karolina
    Gogos, Charalambos
    [J]. RESPIROLOGY, 2020, 25 (11)
  • [5] Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia
    Larsson, Susanna C.
    Burgess, Stephen
    Gill, Dipender
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (01)
  • [6] A role for interleukin-1 receptor antagonism in severe COVID-19?
    Tattersall, Rachel S.
    McGonagle, Dennis
    Manson, Jessica J.
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (10): : E672 - E673
  • [7] Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma
    Chaidos, Aristeidis
    Katsarou, Alexia
    Mustafa, Chira
    Milojkovic, Dragana
    Karadimitris, Anastasios
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (01) : E9 - E11
  • [8] Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concern Reply
    Savinelli, Stefano
    McCarthy, Cormac
    Mallon, Patrick W.
    [J]. RESPIROLOGY, 2020, 25 (11) : 1210 - 1211
  • [9] Rethinking interleukin-6 blockade for treatment of COVID-19
    Scherger, S.
    Henao-Martinez, A.
    Franco-Paredes, C.
    Shapiro, L.
    [J]. MEDICAL HYPOTHESES, 2020, 144
  • [10] Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19
    Vityala, Yethindra
    Tagaev, Tugolbai
    Mamatov, Sagynali
    Aidarov, Ziiabidin
    Harinath, Panchadcharam
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2021, 53 (03) : 246 - 247
12345